| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |